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Abstract  
Introduction: Benign metastasizing leiomyoma (BML) is a rare disease, the first case of BML was reported 
by Steiner in 1939. It can affect any age group ranging from 30 to 75 years, but most commonly found in late 
childbearing period. Leiomyoma of the uterus can metastasize to different organs but lung is the most 
common site, hence the term pulmonary benign metastasizing leiomyoma (PBML) is used. PBML is mostly 
diagnosed incidentally on imaging studies for other conditions. It can occur many years after hysterectomy 
for Leiomyoma of uterus. 
Presentation of the cases: We report a case of a 51 years old lady with chronic cough and pulmonary 
nodules on a computerized  tomography (CT) scan. She was referred to our hospital for the management of 
the probable metastatic cancer. Her diagnosis was challenging but a past history of hysterectomy, radiological 
findings and the histopathology helped us to diagnose this rare condition of benign metastasizing leiomyoma 
(BML). 
Conclusion: Pulmonary benign metastasizing leiomyoma is rare benign disease. It should be considered as 
the probable diagnosis in a female patient with pulmonary nodules and a previous history of surgery for 
leiomyoma of uterus.  Pathological differentiation from leiomyosarcoma and other malignant metastatic 
condition is essential. Prognosis of PBML after surgical and/ or hormonal treatment is good. 
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Introduction 
Benign metastasizing leiomyoma (BML) is a rare disease, the first case of BML was reported 
by Steiner in 1939 [1] [2].
 
It can affect any age group ranging from 30 to 75 years but most 
commonly found in late childbearing period [3]. Leiomyoma of the uterus can metastasize to 
different organs but lung is the most common site, hence the term pulmonary benign 
metastasizing leiomyoma (PBML) is used [4]. PBML is mostly diagnosed incidentally on 
imaging studies for other conditions. It can occur many years after hysterectomy for 
Leiomyoma of uterus [5]. 
Case Presentation 
A 15 year old lady, a mother of four children presented with chronic cough of one year and shortness of 
air (SOA) of two weeks duration. Cough, which was mostly dry but occasionally expectorating small 
amount of white sputum at night, was more pronounced in the month preceding the hospital admission.  
She denied any chronic medical illness or exposure to tuberculosis. She denied any other respiratory 
symptoms except dyspnea, but there was no fever, weight loss, decreased appetite or fatigue. She 
never smoked and there were no malignancies in the family. 
 
 
 
Fig. 1 Chest radiograph of PBML       
 
 
 
 
 
 
 
Fig 2（left）PET-CT scan showing pulmonary nodules (PBML) 
Fig 3（Right）CT scan showing pulmonary nodules (PBML). 
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She had hysterectomy for uterine fibroid 15 years prior to presentation. She was referred to 
medical oncology department with presumed diagnosis of multiple lung metastases of unknown 
primary. She was mildly dyspnoeic with respiratory rate of 18 breath per minute but clear breath 
sounds on auscultation. Her other clinical examination was unremarkable. Oxygen saturation on pulse 
oxymeter was 90% on room air for which she was started on 3  liters of oxygen. 
  
 
Fig4 A（left）histopathology from the lung lesion shows, spindle cell neoplasm with rare mitosis and mild celluar 
and nuclear atypia. B (right）: Immunohistochemistry for ER and PR are positive. 
 
Chest x-ray (CXR) reported bilateral pulmonary nodules; the largest was in the left upper lobe and 
measured 7x8 cm (Fig1). Positron emission tomography (PET)/CT scan showed multiple bilateral 
FDG avid pulmonary nodules with no evidence of FDG avid disease elsewhere (Fig 2,3). The 
SUVmax (standardized uptake value) of different lung nodules ranged from 3 to 6. 
   There was no evidence of pulmonary embolism, interstial fibrosis or consolidation. Ultrasound of 
the pelvis was unremarkable. Based on radiological investigations she was initially diagnosed to have 
a metastatic malignancy of unknown primary. 
Pulmonary lesion CT guided biopsy was arranged and histopathology reported as mild to 
moderate cytological atypia and focal mucoid degeneration, no mitosis or definite coagulative tumor 
necrosis. Immunostains of tumor cells were positive for desmin, ER, PR and Smooth muscle actin. 
The pathological diagnosis of metastatic low grade smooth muscle neoplasm was made.  
Her case was discussed in the  tumor board and pathology slides were reviewed. Repeat biopsy of the 
lung nodule with a bigger tissue was recommended by the  tumor board. 
Wedge resection was performed through the Left video assisted thoracoscopic surgery (VATS). 
The biopsy reveled spindle cell neoplasm with smooth muscle differentiation with mild cellular and 
nuclear atypia (fig 4 A). Histopathology reported Immunostains of tumor cells positive for smooth 
muscle actin, caldesmon, ER and PR (fig 4 B). Immunostains were negative for S100 protein. The 
Ki-67 was less than 5% and the final diagnosis was confirmed as metastasizing leiomyoma. 
Cytogenetic studies with FISH (Flouresence in situ hybridization) reported no deletions in 
chromosomes 19 and 22. Pathology paraffin blocks and slides from hysterectomy fifteen years ago 
were not available for a review. 
The case was discussed again in the tumor board meeting and thoracic surgeon was consulted for 
her management. In view of multiple lung nodules it was considered to be unresectable.  
The patient was informed that the final diagnosis is PBML and she was started on daily Letrozole 
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2.5 mg. Her cough, dyspnoea and hypoxia were significantly improved within 3 weeks of treatment. 
Oxygen saturation improved to 96% on room air upon discharge. On six weeks clinic follow up 
examination, she was clinically well and had no cough or dyspnoea. A CXR did not show any 
radiographic improvement and a CT scan is planned in six weeks. 
Discussion 
Fibroid (leiomyoma) is a benign tumour of the uterus, it accounts for half of the gynaecological  
tumors [6].The risk of malignancy transformation is 0.16 - 6% [7]. 
The pathogenesis of this benign  tumor metastasizing to the lung is not clear. Possible 
mechanisms include hematogenous/ lymphatics spread or proliferation from local smooth muscle 
tissues [8]. The most acceptable theory of dissemination is through venous circulation based on the 
observation that the majority of patients with PBML have a past history of surgery for leiomyoma.  
Our patient had a hysterectomy for leiomyoma 15 years ago. Rarely these metastases are discovered 
simultaneously with uterine fibroid [9]. 
Most patients with PBML are asymptomatic and often discovered incidentally on the chest 
imaging. With disease progression, patients may present with chest pain, cough or even hemoptysis 
[10]. The cause of death in PBML is often respiratory failure [11]. 
PBMLs usually develop many years after a hysterectomy or myomectomy (approximately 14.9 
years). Pulmonary lesions are often bilateral (70%), unilateral in 17% and solitary in 13% of cases. 
The average survival after pulmonary resection is 94 months [12]. 
Radiographic images of the chest in PBML usually show multiple well-circumscribed 
non-calcified lung nodules. These nodules can be cavitating. Less commonly radiological presentation 
can be solitary nodule or diffuse miliary lesions [13]. FDG (Fluorodeoxyglucose) uptake on a PET/CT 
scan is usually faint or none [14] and SUVmax (standardized uptake value) ranges between 0.2 and 2.2 
but rarely the uptake can be higher, as in our patient the a SUVmax was 3 to 6 . 
Diagnosis of PBML is based on presence of benign-appearing smooth muscle tumors outside the 
uterus. The cells have low mitotic index (<5 mitoses per 10 high power fields), lack of pleomorphism 
and no local invasion. The tumor usually stains for estrogen receptor (ER) and progesterone receptor 
(PR) and smooth muscle actin (SMA) [2, 8] [15]. Vimentin, smooth muscle actin, desmin, ER and PR 
expression is present in 80% of the cases. Low Ki-67 proliferative index is noted in PBML with ratios 
reported to be 2.3% and 2.9% in two different studies. Ki-67 expression in leiomyosarcoma (LMS) 
was reported as 28.6% and 11%. [16], In Our patient Ki-67 was reported as less than 5%. Deletion in 
the longer arm of chromosomes 19 and 22 is frequently noticed in LMS but not in BML [4]. Our 
patient did not have deletions in chromosome 19, which supports the diagnosis of BML. Identical 
clone molecular studies on BML and leiomyoma were reported in the literature [4] [17] . 
Although there is no standard treatment known but surgical resection of the pulmonary nodules is 
preferred[11]. Unresectable pulmonary nodules can be treated medically with hormonal manipulation 
(using anastrozole, tamoxifen, raloxifene, progesterone GnRH agonists) or surgically (bilateral 
oophorectomy) [9, 18]. Our patient’s pulmonary nodules were deemed unresectable and so she was 
treated with hormonal manipulation and achieved an excellent clinical response. 
Conclusion: 
Pulmonary benign metastasizing leiomyoma is rare benign disease. It should be considered as the 
probable diagnosis in a female patient with pulmonary nodules and a previous history of surgery for 
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leiomyoma of uterus. Pathological differentiation from leiomyosarcoma and other malignant 
metastatic condition is essential. Prognosis of PBML after surgical and/ or hormonal treatment is good.  
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